| 000 | 01222 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516033948.0 | ||
| 264 | 0 | _c20120507 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.2011.579560 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuintás-Cardama, Alfonso | |
| 245 | 0 | 0 |
_aNew JAK2 inhibitors for myeloproliferative neoplasms. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cJul 2011 |
||
| 300 |
_a961-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Marrow Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aVerstovsek, Srdan | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 20 _gno. 7 _gp. 961-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.2011.579560 _zAvailable from publisher's website |
| 999 |
_c20786052 _d20786052 |
||